Results 161 to 170 of about 48,983 (212)

A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS). [PDF]

BMC Pharmacol Toxicol
Xiong X, Zhang X, Tang F, Huang T.
europepmc   +1 more source

Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system. [PDF]

BMC Cancer
Gao R, Liang W, Chen J, Yang M, Yu X, Wang X.   +5 more
europepmc   +1 more source

Gastrointestinal adverse events associated with Lenvatinib versus Lenvatinib plus Pembrolizumab: A pharmacovigilance study in FDA adverse event reporting system. [PDF]

Sci Rep
Ding C, Ma L, Liang Y, Zhang Z, Wu Q, Lyu J, Su L.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pharmacovigilance in Perspective

Drug Safety, 1999
Pharmacovigilance is more than spontaneous reporting alone, and the evaluation of marketed medicines is more than just pharmacovigilance. The positioning of a drug usually takes place during the years following introduction, when worldwide experience has accumulated.
Meyboom, R.H.B., Egberts, A.C.G., Gribnau, F.W.J., Hekster, Y.A.   +3 more
openaire   +5 more sources

Forensic pharmacovigilance: Newer dimension of pharmacovigilance

Journal of Forensic and Legal Medicine, 2015
Drug safety for the patients is of paramount importance for a medical professional. Pharmacovigilance attempts to ensure the safety of patients by keeping a close vigil on the pattern of adverse events secondary to drug use. Number of medicolegal cases is at rise since last few years. Forensic sciences and pharmacovigilance need to work hand in hand to
Rakesh K. Sewal, Vikas K. Saini, Bikash Medhi   +2 more
openaire   +3 more sources

Pharmacovigilance in pediatrics

Therapies, 2018
The characteristics of pharmacology and drug evaluation in the pediatric age group highlight the necessity for the pharmacovigilance community to adjust to the specific features of children. At the time of marketing a medicinal product intended for children, the product's safety profile is sometimes less well known than for adults due to fewer or small
Annie Pierre Jonville-Béra, Émilie Bouquet, Geneviève Durrieu, Kristina Star   +3 more
openaire   +3 more sources

Pharmacovigilance in Poland

Pharmacoepidemiology and Drug Safety, 1997
History and current status of monitoring of adverse drug reactions in Poland is presented. The Centre for Monitoring of Adverse Drug Reactions (ADR) was established in 1971. The number of suspected drug reactions reported varied in subsequent years. In the analysed periods of time 1972-1984 and 1985-1994, 956 and 961 reports were received respectively.
Andrzej Czarnecki, Agata Maciejczyk
openaire   +2 more sources